Delivery Order SPE2DB24D2205-SPE2DB25FDUAF

Award Date 11/13/24
Potential Completion Date 12/5/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,934.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, a vaccine product. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026....
This federal contract award, valued at $3,701.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML. The contract has a firm fixed price of $7,335 and an ultimate completion date of September 27, 2024. It is a delivery order contract type, and there was no set-aside designation used. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,670.00 firm-fixed-price delivery order contract is for the procurement of COMIRNATY 2024-25 (12Y UP) vaccine syringes (0.3ML) to support military healthcare programs. The award has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of COMIRNATY (Pfizer-BioNTech COVID-19) vaccines to support the Defense Logistics Agency (DLA) Troop Support Medical. The $2,862.24 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024. The contract has an ultimate completion date of December 4, 2024 and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $5,724.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY 2024-25(12Y UP) SYRG 0.3ML, a vaccine product, with a completion date of December 5, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,523.18, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the supply of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, a vaccine product, with an ultimate completion date of...
This federal contract award is for the procurement of COMIRNATY 2024-25(12Y UP) SYRG 0.3ML vaccines, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $7,402.80 firm fixed-price delivery order contract has an ultimate completion date of December 30, 2024. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of COMIRNATY COVID-19 vaccines for those aged 12 years and up. The $14,670 firm fixed-price delivery order has a completion date of November 13, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,402.80 firm fixed-price delivery order is for the supply of COMIRNATY 2024-25 (12 years and up) vaccine syringes (0.3 mL) with a completion date of December 24, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDUAF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML vaccines. The award, valued at $10,733.40, is a firm-fixed-price delivery order with a completion date of December 5, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award is not designated as a set-aside contract. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's medical supply procurement programs.

Generated 2/12/25, 9:21 AM